Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
With the more recent validation studies, have you integrated the use of DCISion RT into your practice?
What patients, if any, do you use DCISion RT in consideration of management?
Related Questions
What is your preferred PMRT dose/fractionation for patients with implant reconstruction?
Would you offer RNI for young patient with cT3N0 triple negative breast cancer that had progression of disease during neoadjuvant chemotherapy, followed by mastectomy and sentinel node biopsy?
How would you treat a patient with a prior history of an early-stage breast cancer who now has a 5 cm tumor in this ipsilateral breast with nodal involvement?
Would you cover regional nodes in an early-stage breast cancer with a non-mapping sentinel lymph node?
For path CR after neoadjuvant chemotherapy in breast cancer with sentinel node (2-3 nodes) negative but >4 nodes positive on initial PET, do you boost the nodes not assessed by sentinel node?
How do you approach the discussion with a patient who is seeking proton therapy for early stage breast cancer?
Do you ever treat a recurrent breast cancer with RNI alone rather than chest wall and RNI?
Do you prefer to use the FAST or FAST-Forward regimen when treating stage I breast cancer with an ultra-hypofractionated approach?
Would you consider a FAST-forward fractionation for a cT1a IDC with DCIS that was found to be pTis on lumpectomy specimen?
What evidence supports the use of high tangents for pN1mic breast cancer?